The Brain’s Built-In Metronome
Updated
Like all things in sync, the human brain keeps time. When it is working well, vast numbers of neurons fire in loose unison in a rhythm, an incredible ensemble that scientists can actually measure. Yet, when memory begins to fail, that incredible rhythm starts to fray, with some regions of the brain keeping the harmonic rhythm while others drift into their own frazzled tempos. The brain becomes a hodgepodge of static noise, with memory, attention, and ordinary daily thoughts harder to access. Researchers have long searched for ways to switch the brain’s ensemble back onto the same count for years. And it turns out that one of the simplest signals that appears to do the trick is a steady beat, 40 times per second, delivered as flickering light, pulsing sound, or both.
Sitting in the gamma range, 40 hertz is a glorious band of electrical activity that the brain uses for activities like paying close attention, forming memories, or coordinating distant regions. In a healthy brain, these rhythms come and go, but in early cognitive decline, they weaken. The idea that an outside signal might be able to pull the brain back towards its own gamma pace is not new. But what is new is real evidence demonstrating that doing so produces real, measurable effects, less plaque, better waste clearance, and slower mental decline.
In 2019, for one hour per day for seven days, researchers at MIT played pure 40 Hz tones to mice that were carrying the genetic change that produces Alzheimer’s-like amyloid plaques in the brain. After the seven days, the amount of amyloid, the protein that forms those plaques, dropped in the hippocampus, a structure essential for forming new memories. The tones entered through the ears, yet the clearest drop in amyloid occurred in the hippocampus, a memory structure well removed from the auditory cortex. Microglia, the brain’s resident immune cells, shifted into those same areas and looked more active. And the mice also scored better on tests of spatial memory. Later, when researchers combined sound with flickering light at the same 40 Hz frequency, plaque reduction spread more widely across the cortex.
The process is called entrainment. In what is clearly a testament to the body’s natural rhythm and healing, entrainment happens when an outside rhythm coaxes neurons in the brain into firing together, in sync with the beat, much like a metronome pulls a musician into correct time. That synchronized firing is directly tied to attention and memory. When it weakens, internal signals in the brain scatter. But feeding the rhythm back into the brain from the outside appears to help them line back up, giving the brain a chance to clear away the collected debris that is causing the static.
The 2019 research revealed exciting details, and a 2024 paper published in Nature added a second layer. In another study using mice, the same 40 Hz light-and-sound stimulation was shown to increase the flow of cerebrospinal fluid through the glymphatic system, which is the network of channels that rinses metabolic waste from the brain, mostly during sleep. In the mice treated using 40 Hz stimulation, more fresh, clean fluid flowed into the brain, and more of the waste-filled water between the cells drained out. To back this up, greater amounts of amyloid that had been cleared showed up in the cervical lymph nodes, which is the drainage destination for fluid from the brain. When researchers blocked the glymphatic pathway, the plaque-clearing effect stopped, illustrating the amazing rhythm inside living beings. In other words, the benefit of 40 Hz is not only electrical. It is also hydraulic. Meaning, the brain’s plumbing functions properly when gamma rhythm is restored.
As noted, these studies were performed using mice, not humans. Still, human data, although still early, points in the same direction. In a small pilot study of people with mild Alzheimer’s disease, participants were instructed to use combined 40 Hz light and sound for an hour each day. After three months of doing so, individuals with mild Alzheimer’s who received the sound and light stimulation showed no significant increase in ventricular volume or loss of hippocampal volume, while the control participants, also with mild Alzheimer’s, exhibited the atrophy expected with disease progression.
The difference in the results between the people in the treatment group and the placebo group was significant, and not by chance. The brains of participants getting the sham signal in the placebo group shrank in line with the progression of Alzheimer’s. And the brains of those receiving the 40 Hz signal held mostly steady, with their memory network – the regions used for recall and to think inward – connected together better than before the study. When the study ended, a handful of participants, aware they were using the actual device, kept applying the signal an hour a day for months. The result? Their mental decline still appeared to slow down. With larger controlled trials still underway, researchers are quick to point out that, thus far, the results prove very little. Except, of course, that a frequency the brain already makes, when fed back in from the outside, changes the brain’s physiology enough to apparently slow down the progression of Alzheimer’s.
No, patients with Alzheimer’s can’t simply pull up a 40 Hz track and sync it with their brains every night. The study used a precise 40 Hz flicker (yes, LED light and its blue spike, but only a deliberate, one-hour signal) locked to a precise 40 Hz tone set at specific intensities for a full hour. But, with FDA Breakthough Device Designation in place (a status the speeds review, not an approval), a company called Cognito Therapeutics, founded on the original MIT work, is moving forward with its light-and-sound headset, called Spectris. Currently, Spectris remains investigational and unapproved, but its hour-a-day stimulation at home is in late-stage trials. Indeed, if the trials hold, let’s hope the price is right when this therapy makes its debut, and that getting it is easier than most holistic-leaning treatments tend to be.